Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Mission Hospital, Inc
mi
from
Asheville, NC
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Duke University
mi
from
Durham, NC
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Ohio State University
mi
from
Columbus, OH
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Baylor Research Institute
mi
from
Plano, TX
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Baylor Research Institute
mi
from
Plano, TX
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Virginia
mi
from
Charlottesville, VA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Alberta Hospital
mi
from
Edmonton,
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Alberta Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)
Correlation Between FlowMet™, ABI, SPP, TBI, TcPO2 and Angiography
Status: Enrolling
Updated:  4/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)
Correlation Between FlowMet™, ABI, SPP, TBI, TcPO2 and Angiography
Status: Enrolling
Updated: 4/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
Improving Heart Failure Risk Stratification in the ED
Status: Enrolling
Updated:  4/18/2017
University of Cincinnati
mi
from
Cincinnati, OH
Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
Improving Heart Failure Risk Stratification in the ED
Status: Enrolling
Updated: 4/18/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Non Invasive Neuromonitoring After Cardiac Arrest
Phase 2 Prospective, Observational, Pilot Study of Noninvasive Monitoring of Regional Cerebral Blood Flow for the Evaluation of Brain Tissue Perfusion During and After Resuscitation for Cardiac Arrest
Status: Enrolling
Updated:  4/18/2017
Mount Sinai Hosp
mi
from
New York, NY
Non Invasive Neuromonitoring After Cardiac Arrest
Phase 2 Prospective, Observational, Pilot Study of Noninvasive Monitoring of Regional Cerebral Blood Flow for the Evaluation of Brain Tissue Perfusion During and After Resuscitation for Cardiac Arrest
Status: Enrolling
Updated: 4/18/2017
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Stanford University
mi
from
Palo Alto, CA
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Yale University
mi
from
New Haven, CT
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Emory University
mi
from
Atlanta, GA
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Indiana University
mi
from
Indianapolis, IN
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
University of Iowa
mi
from
Iowa City, IA
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Tufts Medical Center
mi
from
Boston, MA
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Wayne State University
mi
from
Detroit, MI
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
University of New Mexico
mi
from
Albuquerque, NM
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
RTI International
mi
from
Durham, NC
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
RTI International
mi
from
Durham, NC
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Duke University
mi
from
Durham, NC
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated:  4/18/2017
University of Utah
mi
from
Salt Lake City, UT
Early Blood Pressure Management in Extremely Premature Infants
Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study
Status: Enrolling
Updated: 4/18/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
Comparison of Coagulation Parameters in Arterial and Venous Blood Measured Using the Quantra System
Status: Enrolling
Updated:  4/18/2017
University of Virginia
mi
from
Charlottesville, VA
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
Comparison of Coagulation Parameters in Arterial and Venous Blood Measured Using the Quantra System
Status: Enrolling
Updated: 4/18/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated:  4/19/2017
Foundation for Cardiovascular Medicine
mi
from
La Jolla, CA
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated: 4/19/2017
Foundation for Cardiovascular Medicine
mi
from
La Jolla, CA
Click here to add this to my saved trials
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated:  4/19/2017
Mount Sinai Hosp
mi
from
New York, NY
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated: 4/19/2017
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated:  4/19/2017
AMC
mi
from
Amsterdam,
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Status: Enrolling
Updated: 4/19/2017
AMC
mi
from
Amsterdam,
Click here to add this to my saved trials
The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Status: Enrolling
Updated:  4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Status: Enrolling
Updated: 4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Augusta, GA
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Cleveland, OH
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated:  4/19/2017
GSK Investigational Site
mi
from
Toronto,
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Status: Enrolling
Updated: 4/19/2017
GSK Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease
The Relationship Between Diet, Perception of Healthy Lifestyle and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography.
Status: Enrolling
Updated:  4/19/2017
New York University School of Medicine
mi
from
New York, NY
Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease
The Relationship Between Diet, Perception of Healthy Lifestyle and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography.
Status: Enrolling
Updated: 4/19/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry
Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry
Status: Enrolling
Updated:  4/19/2017
Clinimark Laboratories
mi
from
Louisville, CO
Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry
Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry
Status: Enrolling
Updated: 4/19/2017
Clinimark Laboratories
mi
from
Louisville, CO
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Carondelet Heart and Vascular Institute
mi
from
Tucson, AZ
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Carondelet Heart and Vascular Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
University of California, San Diego (UCSD)
mi
from
La Jolla, CA
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
University of California, San Diego (UCSD)
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Alliance Research Centers
mi
from
Laguna Hills, CA
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Alliance Research Centers
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
University of Florida
mi
from
Gainesville, FL
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Sarasota Memorial Hospital - Clinical Research Center
mi
from
Sarasota, FL
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Sarasota Memorial Hospital - Clinical Research Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Emory University
mi
from
Atlanta, GA
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  4/24/2017
Harbin Clinic
mi
from
Rome, GA
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Harbin Clinic
mi
from
Rome, GA
Click here to add this to my saved trials